Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes. Vidal-Jordana A, Sastre-Garriga J, Pérez-Miralles F, Tur C, Tintoré M, Horga A, Auger C, Río J, Nos C, Edo MC, et al. Mult Scler. 2013 Aug; 19(9):1175-81. Epub 2013 Jan 14. PMID: 23319072. Abstract CommentRecommendBookmarkWatch